Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Thrombolysis in Acute Ischemic Stroke Patients on NOACs
NCT06749834Phase 3Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Metabolic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator, tenecteplase, reteplase, recombinant human prourokinase in ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jan 2025; status: recruiting.
02
Drugs
tissue-plasminogen activatortenecteplasereteplaserecombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06749834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06749834.